Bankrupt uBiome sells off patents, data for $7M; J&J buys options on Pulmatrix's lung cancer drugs
→ In the final chapter of disgraced gut testing player uBiome’s story, Psomagen has acquired all its key assets in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
